Capricor Therapeutics, Inc. is a clinical-stage biotechnology company that focuses on developing cell and exosome-based therapeutics for diseases with unmet medical needs, such as Duchenne muscular dystrophy (DMD). Despite the…

Subscribe Now for Real-time Updates on the Latest Stories!
Oil prices experienced a decline on Friday as major European nations and Japan offered to assist in ensuring safe passage…
Scholastic Corporation recently released its Q3 2026 earnings call summary, outlining key highlights and future projections for the company. One…
U.S. Department of Justice Clears Nexstar's Acquisition of Tegna March 19 (Reuters) - The U.S. Department of Justice has unconditionally…
The recent halt to oil and LNG supply at the Strait of Hormuz has sent shockwaves through major energy-consuming regions,…
Mortgages are a significant component of household debt in the United States, with the average American owing $258,214. Millennials carry…
Nvidia (NVDA) is undeniably the top high-performance computing semiconductor stock in the market, solidifying its position as the most valuable…
Shopify Inc. (SHOP) has been making waves in the commerce technology industry, providing tools for businesses of all sizes to…
Oracle (ORCL) has been facing some challenges recently, but there are positive signs on the horizon. Analyst Siti Panigrahi at…
Sign in to your account